{"id":"91e0c159-34d9-4b78-8e8f-3b4a9c09da8a","kind":"institutions","code":"UB-I2465","name":"NantWorks","nameBasis":"original-brand","summary":"NantWorks, a corporate investment entity undertaking strategic investments.","description":"NantWorks, a corporate investment entity undertaking strategic investments.","country":null,"category":null,"originalName":"NantWorks","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:27.911Z","englishUpdatedAt":"2026-10-15T17:35:39.399Z","reviewedAt":"2026-10-15T17:35:39.399Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"9c34d3796e9091b9a16f489dcf28859769707cff75d2bb9c070a7a54b9888578","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"NantWorks，开展战略投资的企业投资主体。","sources":[],"related":[{"id":"392f1e48-072e-49a7-888a-2ba984507dca","kind":"news","code":"392f1e48-072e-49a7-888a-2ba984507dca","name":"Multiply Labs raises USD 75 million in Series B funding to automate pharmaceutical manufacturing with robots","nameBasis":"translated-title","summary":"On 2026/10/8, AIPressRoom reported that Multiply Labs raised USD 75 million in Series B funding, led by Patrick Soon-Shiong and NantWorks. It uses robotic systems to automate biologic drug production, improving pharmaceutical manufacturing efficiency and quality consistency.","description":"","country":null,"category":null,"originalName":"Multiply Labs完成7500万美元B轮融资，机器人制药生产自动化","eventDate":"2026-10-08T00:00:00.000Z","website":"https://aipressroom.com/multiply-labs-75m-robotic-manufacturing/","sourceUpdatedAt":"2026-10-15T06:00:19.301Z","englishUpdatedAt":"2026-10-15T22:53:07.222Z","reviewedAt":"2026-10-15T22:53:07.222Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"c6988d1531ff6d2720632275ed09a90c79a73b7e6122e2d8c027c8a7569f68ae","companyId":"c2752964-aed9-4c93-85cd-369af262ef2d","foundedYear":null,"logoUrl":null,"path":"/news/392f1e48-072e-49a7-888a-2ba984507dca"}],"path":"/institutions/nantworks","canonical":"https://uniquebase.ai/institutions/nantworks"}